1778 - DALBAVANCINA EN ENDOCARDITIS INFECCIOSA E INFECCIONES EN DISPOSITIVOS DE ELECTROESTIMULACIÓN CARDÍACA
Daniel Encinas Sánchez, María Sánchez Ledesma(Complejo Hospitalario de Salamanca), Álvaro Moreno Gómez, Eduardo Villacorta(Complejo Hospitalario de Salamanca), Guillermo Hernández Pérez, David González Calle(Universidad de Salamanca), David Puertas Miranda, Moncef Belhassen‐García(Universidad de Salamanca)
Cited by 0
Related Papers
Crimean-Congo Hemorrhagic Fever, Spain, 2013–2021
|Emerging infectious diseases|2023|81
Predicting Success and Long-Term Outcomes of Percutaneous Mitral Valvuloplasty: A Multifactorial Score
|The American Journal of Medicine|2009|52
Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction
|Journal of Cellular and Molecular Medicine|2008|51
Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry
|European Heart Journal - Quality of Care and Clinical Outcomes|2022|45